title: [Doses of biogenetic human insulin for the treatment of diabetics with anti-insulin antibodies].
authors.forename: D
authors.initials: D
authors.lastname: Chadenas
authors.forename: F
authors.initials: F
authors.lastname: de la Forest Divonne
authors.forename: B
authors.initials: B
authors.lastname: Harang
authors.forename: C
authors.initials: C
authors.lastname: Bidault
authors.forename: D
authors.initials: D
authors.lastname: Pinsard
authors.forename: G
authors.initials: G
authors.lastname: Picaper
mesh_terms: D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D007330:Insulin Antibodies; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage*
chemical_list: D007328:Insulin; D007330:Insulin Antibodies; D011994:Recombinant Proteins
vernacular_title: Les doses d'insuline humaine biogénétique pour le traitement du diabétique ayant des anticorps anti-insuline.